SLS
Sellas Life Sciences Group Inc
11.60$
-0.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.5% | -4.2% | -29.8% | +14.1% | -2.1% | +35.4% | -0.8% | +0.4% | -11.1% | +78.5% | +27.2% | – | |
| – | +57.1% | -167.3% | – | – | – | – | – | – | – | -165.1% | – | – | |
| – | +83.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -181.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6,170.4% | +686.9% | -98.4% | +4,656.0% | -100.0% | +294,662.5% | -82.1% | +516.8% | +24.2% | +36.3% | -12.0% | – | |
| – | – | – | -158.3% | – | -160.1% | – | -121.4% | – | +44.4% | +28.5% | -11.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.